期刊文献+

个体差异的细胞因子高表达与造血干细胞移植后的复发相关性探讨

The association between relapse and high expression of cytokines caused by individual differences after allogeneic HSCT
下载PDF
导出
摘要 目的分析造血干细胞移植(HSCT)后复发与个体差异的细胞因子高表达的关系。方法分别采集24名异基因造血干细胞移植(allo-HSCT)患者移植前后(-13、0、7、14、21、26和30 d)的系列血样,4名健康人作为对照采集血样周期同患者,分别制备血浆、DNA、RNA;血浆用于细胞因子GM-CSF、IFN-γ、IL-1β、IL-2、IL-4、IL-5、IL-6、IL-8、IL-10及TNF-α检测;DNA用于信息STR位点谱定量分析嵌合物;RNA用于定量检测BCR-ABL融合基因的肿瘤负载。结果信息STR位点谱定量分析嵌合物结合BCR-ABL融合基因的肿瘤负载,确认出4名患者为慢性粒细胞性白血病复发,另有1人根据临床表现诊断为急性粒细胞性白血病复发,1人死于急性移植物抗宿主病。对5名复发患者、18名缓解患者移植前后10种细胞因子浓度(pg/ml)分析发现:复发组与缓解组分别为GM-CSF(57.2±135.8)vs(15.7±37.3)、IL-1β(233.0±330.6)vs(19.2±39.5)、IL-2(178.2±257.0)vs(14.1±41.1)、TNF-α(9.0±18.4)vs(2.6±4.3)、IL-4(28.9±33.5)vs(9.9±10.0),P<0.01),此差异主要是由于5名复发患者中的2例持续高表达IL-1β、IL-2、IL-4,而TNF-α、GM-CSF仅在1例中持续高表达,缓解组18例加上死亡的1例共19例中只有1例GM-CSF持续较高表达。结论 HSCT移植后的复发可能与个体差异的细胞因子高表达相关,且这些细胞因子为成组出现,如IL-1β、IL-2、IL-4同时高表达。建议allo-HSCT患者在移植前后做细胞因子的浓度测定,至少包括IL-1β、IL-2、IL-4。 Objective To explore the association between relapse and high expression of cytokines after allogeneic hematopoietic stem cell transplantation(HSCT).Methods Blood was drawn from 24 patients undergone HSCT and 4 healthy unrelated persons,at transplantation days of-13,0,7,14,21,26,30,and plasma,DNA and RNA were prepared.Plasma samples were used to analyze cytokines including GM-CSF,IFN-γ,IL-1β,IL-2,IL-4,IL-5,IL-6,IL-8,IL-10,and TNF-α,using a ten-plex antibody bead kit,DNA was used to analyze quantitative chimera and RNA was used for BCR-ABL transcript analysis to confirm relapse of clinically suspected patients.Results Through quantitative chimerism and BCR-ABL transcripts analyses,4 patients were confirmed in CML relapse,one was diagnosed as AML relapse by clinical signs.Another patient died of severe acute graft versus host disease.The cytokine concentrations in relapse(5) versus remission(18) were(57.18±135.8) and(15.7±37.3) respectively for GM-CSF,(233.0±330.6) and(19.2±39.5),respectively for IL-1β,(178.2±257.0) and(14.1±41.1),respectively for IL-2,(9.0±18.4)and(2.6±4.3)respectively for TNF-α,and(28.9±33.0)and(9.9±10.0) respectively(pg/ml,P〈0.01)for IL-4.Further observations showed these concentration differences were caused by 2 of 5 relapsed patients,who suffered from sustained high expression of a group of cytokines including IL-1β、IL-2、IL-4.While only one of 19(18 remission plus 1 deceased) was found to have high expression of GM-CSF in non-relapse.Conclusion The relapses after HSCT is possibly related to high expressions of cytokines including IL-1β,IL-2,and IL-4,which were caused by individual differences.It is suggested that cytokine quantitative analysis should be performed on patients underging HSCT,at least including IL-1β,IL-2,and IL-4.
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第5期421-425,共5页 Chinese Journal of Blood Transfusion
基金 上海市科委浦江人才项目(06PJ14080) 上海市卫生局科研项目(2008056)
关键词 异基因造血干细胞移植 个体差异 复发 细胞因子 高表达 急性粒细胞性白血病 急性移植物抗宿主病 Allogeneic hematopoietic stem cell transplantation Individual difference Relapse Cell factor Cytokinehigh expression
  • 相关文献

参考文献11

  • 1Meijer E, Comelissen JJ. Allogeneic stem cell transplantation in a- cute myeloid leukemia in first or subsequent remission:weighing prognostic markers predicting relapse and risk factors for non-re- lapse mortality. Semin Oneol,2008,35 (4) :449-457.
  • 2Lobashevsky AL, Senkbeil RW ,Townsend JE, et al. Quantitative a- nalysis of chimerism using a short tandem repeat method on a fluo- rescent automated DNA sequencer. Clin Lab Haem ,2006,28 ( 1 ) : 40-49.
  • 3Gabert J, Beillard E, Velden VHJ van der, et al. Standardizationand quality eonlxol studies of ' real-time' quantitative reverse tran- scriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-A Europe Against Cancer Program. Leukemia ,2003,17 (12) :2318-2357.
  • 4Ritehle D, Seconi J, Wood C, et al. Prospective monitoring of tumor necrosis factor x and interferon-',/to predict the onset of acute and chronic graft-versus-host disease after allogeneie stem cell trans- plantation. Biol Blood Marrow Transplant ,2005,11 (9) :706-712.
  • 5杨颖,吴文,王玲玲,陈和平,朱自严.适合移植后嵌合物定量分析的信息STR位点谱的建立及其应用[J].中国实验血液学杂志,2009,17(3):706-712. 被引量:5
  • 6Hakan Goker, Ibrahim C. Haznedaroglu, et al. Acute graft-vs-host disease: Pathoblology and management. Exp Hematol, 2001,29 (3) :259-277.
  • 7Ball LM, Egeler RM. Acute GvHD :pathogenesis and classification. Bone Marrow Transplant,2008,41 (Suppl 2) : $58-$64.
  • 8Toubai T, Sun Y and Reddy P. GVHD pathophysiology: is acute different from chronic? Best Pract Res CL HA ,2008,21 (2) :101- 117.
  • 9Pavletic SZ, Lee SJ, Socie G, et al. Chronic graft-versus-host dis- ease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplant,2006,38 ( 10 ) : 645-651.
  • 10Rao DA, Traeey K J, Pober JS. IL-lct and IL-113 are endogenous mediators linking cell injury to the adaptive alloimmune response. J Immuno1,2007,179 ( 10 ) : 6536-6546.

二级参考文献15

  • 1Lion T,Muller-Berat N.Chimerism testing after allogeneic stem cell transplantation:importance of timing and optimal technique for chimerism testing in different clinical-biological situations.Leukemia,1999, 13:2095-2086
  • 2Lawler M,McCann SR,Conneally E,et al.Chimaerism following allogeneic bone marrow transplantation, detection of residual host cells using the polymerase chain reaction.Br J Haematol,1989 ,73:205 -210
  • 3Bader JF,Klingebiel T,Schaudt A,et al.Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism:a single center experience of 12 children.Leukemia,1999, 13:2079-2086
  • 4Hancock JP,Goulden NJ,Oakhill A,et al.Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR.Leukemia,2003,17:247-251
  • 5Hauge XY,Litt M.A study of the origin of 'shadow bands'seen when typing dinucleotide repeat polymorphisms by the PCR.Hum Mol Genet,1993,2:411 -415
  • 6Walsh PS,Fildes NJ,Reynolds R.Sequence analysis and characterization of stutter products at the tetranucleotide repeat locus vWA.Nucleic Acids Res,1996,24:2807 -2812
  • 7Hoffmann SC,Stanley EM,Cox ED,et al.Ethnicity greatly influences cytokine gene polymorphism distribution[J].Am J Transplant,2002,2(6):560-567.
  • 8Bathgate AJ,Pravica V,Perrey C,et al.The effect of polymorphisms in tumor necrosis factor-alpha,interleukin-10,and transforming growth factor-beta1 genes in acute hepatic allograft rejection[J].Transplantation,2000,69(7):1514-1517.
  • 9Jonsson JR,Hong C,Purdie DM,et al.Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation[J].Liver Transpl,2001,7(3):255-263.
  • 10Warle MC,Farhan A,Metselaar HJ,et al.Cytokine gene polymorphisms and acute human liver graft rejection[J].Liver Transpl,2002,8(7):603-611.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部